Publicaties


  • ‘Authors’ reply to Mungmunpuntipantip et al.’s Comment on “Description of frequencies of Reported adverse events following immunization among four different COVID-19 Vaccine Brands”
    Kant A, van Hunsel F
    15-7-2022
  • Information needs and counseling preferences among potential users of the future Teratology Information Service in Belgium: A cross-sectional study involving the public and healthcare professionals
    Ceulemans M, van Calsteren K, Allegaert K, Foulon V
    14-7-2022
  • Geneesmiddel geïnduceerde lichtgevoeligheid
    Weits G, Ederveen E
    8-7-2022
  • Behandeling met propranolol verhoogt risico op hypoglykemie
    von Kreijfelt G
    1-7-2022
    Pharmaceutisch Weekblad
  • Kan ik gaan stotteren van mijn ADHD-medicatie?
    van Es M
    30-6-2022
    Impuls & Woortblind
  • Using structural topic modelling to reveal patterns in reports on opioid drugs in a pharmacovigilance database
    Lösch L, Brown P, van Hunsel F
    25-6-2022
  • Paracetamol en zwangerschap
    van Es M
    22-6-2022
  • Verkeerd gebruik van basische druppels
    van Es M
    21-6-2022
  • Patient-reported adverse drug reactions attributed to the use of etanercept: distinction based on nature, frequency and burden
    van Boxem L, Gosselt H, Tas S, van den Bemt B, Vonkeman H, Hoentjen F, Nurmohamed M, van Doorn M, Jessurun N
    20-6-2022
    Annals of Rheumatic diseases
  • Self-management strategies for adverse drug reactions as reported by TNF-alpha inhibitor users: an observational study
    Ophoff M, van Lint J, Tas S, van den Bemt B, Vonkeman H, Hoentjen F, Nurmohamed M, Jessurun N
    20-6-2022
    Annals of Rheumatic diseases